We are live on
!
Find out more
AIM
Arcadia Investment Management Portfolio holdings
AUM
$584M
1-Year Est. Return
21.44%
This Fund
S&P 500
This Quarter
Est. Return
+10.35%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$565M
AUM Growth
+$42.1M
(+8%)
Cap. Flow
-$2.06M
Cap. Flow
% of AUM
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
37.22%
Holding
341
New
23
Increased
52
Reduced
104
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mobileye
MBLY
|
+$2.8M |
| 2 |
Air Products & Chemicals
APD
|
+$2.39M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.22M |
| 4 |
Watsco Inc
WSO
|
+$1.62M |
| 5 |
P
Everpure Inc
P
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.56M |
| 2 |
PepsiCo
PEP
|
+$1.42M |
| 3 |
Trane Technologies
TT
|
+$1.18M |
| 4 |
Broadcom
AVGO
|
+$1.17M |
| 5 |
Tractor Supply
TSCO
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.21% |
| 2 | Healthcare | 13.53% |
| 3 | Consumer Discretionary | 10.22% |
| 4 | Industrials | 8.96% |
| 5 | Financials | 6.84% |
Similar funds
KI
HA
CGIM
RIS
TAM
GIM
IIA
DLCIG
Arcadia Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, Arcadia Investment Management held 341 positions worth $565M, up 8% from $523M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arcadia Investment Management's Q1 2024 filing shows 23 new, 52 increased, 104 reduced and 29 closed positions. Its largest new stake was Dyne Therapeutics: 31,325 shares worth $889K. The largest sale was Bristol-Myers Squibb, an estimated $1.56M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Arcadia Investment Management's largest Q1 2024 buy was Dyne Therapeutics: 31,325 shares worth $889K.
- Arcadia Investment Management added most to Mobileye in Q1 2024, an estimated $2.8M increase.
- Arcadia Investment Management's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $1.56M.
- Arcadia Investment Management fully exited East-West Bancorp in Q1 2024, selling an estimated $737K.
- Arcadia Investment Management's ten largest holdings make up 37% of its $565M portfolio in Q1 2024.
- Arcadia Investment Management opened 23 new positions and closed 29 in Q1 2024.
- Arcadia Investment Management's portfolio value rose 8% quarter-over-quarter to $565M.
Based on Arcadia Investment Management's 13F filing for Q1 2024, filed 23 Apr 2024.